Understanding Systemic Therapy
Beyond Localized Treatment
Most regenerative therapies target specific tissues or injuries. Cell Factor’s systemic delivery allows therapeutic extracellular vesicles (EVs) to circulate throughout the body, crossing biological barriers including the blood-brain barrier to deliver regenerative signaling to every organ system.
Through IV infusion or subcutaneous injection, Cell Factor’s nanoscale particles (30-150 nm) distribute systemically, modulating inflammation, enhancing mitochondrial function, and promoting tissue repair across multiple organ systems simultaneously. This whole-body approach addresses the systemic nature of aging and chronic disease.
Research published in Nature Signal Transduction and Targeted Therapy confirms that EVs can cross the blood-brain barrier and influence neurological function, opening new frontiers in neuroprotection and cognitive enhancement.